John Sampson

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

Founded in 1997 by Cameron McVeigh and Leslie Skingle, Camcor Capital, Inc. is a venture capital firm located in Calgary, Alberta.

Raymond James Ltd. (Broker) (Raymond James-Broker) is the broker/dealer division of Raymond James Ltd., a diversified financial services firm headquartered in Vancouver, British Columbia. The firm was founded in 1962 and is ultimately owned by Raymond James Financial, Inc. (NYSE: RJF), a US-based diversified holding company. Raymond James-Broker provides a full array of investment services to corporate and institutional clients.

Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

Camcor Partners, Inc. provides funding for early stage upstream oil and gas private companies. The company was founded in 1997 by Cameron A. McVeigh and is headquartered in Calgary, Canada.

Aztec Components, Inc. distributes electronic components, semiconductors and peripherals. It supplies passive and peripheral components. The company was founded in 1996 and is headquartered in Vista, CA.

Mcmaster Innovation Park operates as a premier research park that offers collaborative space for researchers and entrepreneurs to co-locate, connect and commercialize. The company is headquartered in Hamilton, Canada.

JEG & Associates LLC provides legal services. The private company is based in Suisun City, CA.

Deloitte LLP provides audit, tax, consulting and financial advisory services. Its services include advisory, audit, consulting, human capital, mergers and acquisitions, operations, regulatory, risk and resilience, strategy, tax and technology. The firm serves in financial services, manufacturing, real estate, technology, media, life science and consumer business industries. The company is headquartered in Toronto, Canada.

Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA.

Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA.

Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom.

Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China.

Merrco Payments, Inc. develops cannabis e-commerce and government compliance payment solutions. The firm's technology ensure sellers comply with age restrictions and purchase limits using tools such as device fingerprinting, geo-fencing, and big data collection. The company is headquartered in Calgary, Canada.

TheraCann International Benchmark Corp is a cannabis market company. It is engaged in offering one-stop, full-service solution for the cannabis marketplace including regulatory applications, planning, facility design, cultivation, marketing and communications services. The company was founded in 2004 and is headquartered in Panama City, Panama.

Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom.

F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom.

OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.